Qkine Stock

Qkine is a specialist developer and manufacturer of growth factor proteins for stem cell, organoid and cellular agriculture applications

Sign up today and learn more about Qkine Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Qkine Stock

Qkine manufactures high-purity, animal-free growth factors, cytokines and other complex proteins. Based on the Cambridge Science Park, UK, we combine proprietary protein production processes developed at the University of Cambridge with protein engineering techniques to develop unique products that tackle fundamental biological and scale-up challenges for the fast-growing stem cell, organoid, regenerative medicine and cultivated meat sectors. Qkine has an active R&D pipeline, with a continually expanding product range. Unique products available from Qkine include tag-free thermostable FGF-2 (FGF2-G3), the first animal-free TGF beta 1 for chemically defined stem cell media, and animal-free HGF (NK1). Qkine is an ISO 9001: 2015 certified company.

Funding History

July 2018$20K
June 2019$550K
June 2020$1.5M
December 2022$4.3M


CEO & Founder

Catherine Elton

Director & Foundr

Marko Hyvönen


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: